Oxford Nanopore Technologies (LON:ONT) Receives Buy Rating from Berenberg Bank

Berenberg Bank reissued their buy rating on shares of Oxford Nanopore Technologies (LON:ONT) in a research note issued to investors on Tuesday morning, MarketBeat reports. They currently have a GBX 282 ($3.71) price target on the stock.

Several other equities analysts have also recently weighed in on the company. JPMorgan Chase & Co. reaffirmed an overweight rating on shares of Oxford Nanopore Technologies in a research note on Thursday, May 23rd. Royal Bank of Canada reaffirmed an outperform rating and set a GBX 260 ($3.42) price objective on shares of Oxford Nanopore Technologies in a research report on Friday, June 28th. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, Oxford Nanopore Technologies currently has an average rating of Buy and an average target price of GBX 259.40 ($3.41).

Oxford Nanopore Technologies Stock Performance

Shares of ONT stock opened at GBX 142 ($1.87) on Tuesday. The company has a market capitalization of £1.34 billion, a price-to-earnings ratio of -747.37 and a beta of 0.79. Oxford Nanopore Technologies has a 1-year low of GBX 85 ($1.12) and a 1-year high of GBX 229.40 ($3.02). The company has a current ratio of 5.01, a quick ratio of 6.01 and a debt-to-equity ratio of 6.47. The stock’s fifty day simple moving average is GBX 118.55 and its 200-day simple moving average is GBX 115.77.

Insider Transactions at Oxford Nanopore Technologies

In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 45,466 shares of Oxford Nanopore Technologies stock in a transaction that occurred on Tuesday, July 2nd. The shares were sold at an average price of GBX 96 ($1.26), for a total value of £43,647.36 ($57,392.98). Insiders bought 414 shares of company stock valued at $44,814 in the last three months. Corporate insiders own 34.49% of the company’s stock.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.